• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成纤维细胞生长因子 21 是胰高血糖素样肽-1 受体激动剂利拉鲁肽诱导雄性高糖饮食喂养小鼠体重减轻所必需的。

Fibroblast growth factor-21 is required for weight loss induced by the glucagon-like peptide-1 receptor agonist liraglutide in male mice fed high carbohydrate diets.

机构信息

Department of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, 2215 Garland Avenue, Nashville, TN 37232, USA.

Department of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, 2215 Garland Avenue, Nashville, TN 37232, USA.

出版信息

Mol Metab. 2023 Jun;72:101718. doi: 10.1016/j.molmet.2023.101718. Epub 2023 Apr 7.

DOI:10.1016/j.molmet.2023.101718
PMID:37030441
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10131131/
Abstract

OBJECTIVE

Glucagon-like peptide-1 receptor (GLP-1R) agonists (GLP-1RA) and fibroblast growth factor-21 (FGF21) confer similar metabolic benefits. GLP-1RA induce FGF21, leading us to investigate mechanisms engaged by the GLP-1RA liraglutide to increase FGF21 levels and the metabolic relevance of liraglutide-induced FGF21.

METHODS

Circulating FGF21 levels were measured in fasted male C57BL/6J, neuronal GLP-1R knockout, β-cell GLP-1R knockout, and liver peroxisome proliferator-activated receptor alpha knockout mice treated acutely with liraglutide. To test the metabolic relevance of liver FGF21 in response to liraglutide, chow-fed control and liver Fgf21 knockout (Liv) mice were treated with vehicle or liraglutide in metabolic chambers. Body weight and composition, food intake, and energy expenditure were measured. Since FGF21 reduces carbohydrate intake, we measured body weight in mice fed matched diets with low- (LC) or high-carbohydrate (HC) content and in mice fed a high-fat, high-sugar (HFHS) diet. This was done in control and Liv mice and in mice lacking neuronal β-klotho (Klb) expression to disrupt brain FGF21 signaling.

RESULTS

Liraglutide increases FGF21 levels independently of decreased food intake via neuronal GLP-1R activation. Lack of liver Fgf21 expression confers resistance to liraglutide-induced weight loss due to attenuated reduction of food intake in chow-fed mice. Liraglutide-induced weight loss was impaired in Liv mice when fed HC and HFHS diets but not when fed a LC diet. Loss of neuronal Klb also attenuated liraglutide-induced weight loss in mice fed HC or HFHS diets.

CONCLUSIONS

Our findings support a novel role for a GLP-1R-FGF21 axis in regulating body weight in a dietary carbohydrate-dependent manner.

摘要

目的

胰高血糖素样肽-1 受体(GLP-1R)激动剂(GLP-1RA)和成纤维细胞生长因子 21(FGF21)具有相似的代谢益处。GLP-1RA 诱导 FGF21,这促使我们研究 GLP-1RA 利拉鲁肽增加 FGF21 水平的机制以及利拉鲁肽诱导的 FGF21 的代谢相关性。

方法

在急性给予利拉鲁肽的禁食雄性 C57BL/6J、神经元 GLP-1R 敲除、β细胞 GLP-1R 敲除和肝过氧化物酶体增殖物激活受体α敲除小鼠中测量循环 FGF21 水平。为了测试肝脏 FGF21 对利拉鲁肽反应的代谢相关性,在代谢室内用载体或利拉鲁肽处理正常饮食喂养的对照和肝脏 Fgf21 敲除(Liv)小鼠。测量体重和组成、食物摄入量和能量消耗。由于 FGF21 降低碳水化合物的摄入量,我们在给予低(LC)或高碳水化合物(HC)含量匹配饮食的小鼠以及给予高脂肪、高糖(HFHS)饮食的小鼠中测量体重。在对照和 Liv 小鼠以及缺乏神经元β-klotho(Klb)表达以破坏大脑 FGF21 信号的小鼠中进行了这项研究。

结果

利拉鲁肽通过神经元 GLP-1R 激活增加 FGF21 水平,而不依赖于降低食物摄入量。缺乏肝脏 Fgf21 表达会导致利拉鲁肽诱导的体重减轻抵抗,因为在正常饮食喂养的小鼠中食物摄入量的减少减弱。在给予 HC 和 HFHS 饮食的 Liv 小鼠中,利拉鲁肽诱导的体重减轻受损,但在给予 LC 饮食的小鼠中没有受损。神经元 Klb 的缺失也减弱了给予 HC 或 HFHS 饮食的小鼠中利拉鲁肽诱导的体重减轻。

结论

我们的研究结果支持 GLP-1R-FGF21 轴在以饮食碳水化合物依赖的方式调节体重方面的新作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53a9/10131131/e518c40ee87d/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53a9/10131131/7bdebf341a8e/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53a9/10131131/ff69e16e0ecf/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53a9/10131131/560d59fedb40/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53a9/10131131/6f1da709ca30/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53a9/10131131/b824b314236f/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53a9/10131131/e518c40ee87d/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53a9/10131131/7bdebf341a8e/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53a9/10131131/ff69e16e0ecf/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53a9/10131131/560d59fedb40/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53a9/10131131/6f1da709ca30/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53a9/10131131/b824b314236f/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53a9/10131131/e518c40ee87d/gr5.jpg

相似文献

1
Fibroblast growth factor-21 is required for weight loss induced by the glucagon-like peptide-1 receptor agonist liraglutide in male mice fed high carbohydrate diets.成纤维细胞生长因子 21 是胰高血糖素样肽-1 受体激动剂利拉鲁肽诱导雄性高糖饮食喂养小鼠体重减轻所必需的。
Mol Metab. 2023 Jun;72:101718. doi: 10.1016/j.molmet.2023.101718. Epub 2023 Apr 7.
2
Liver Fibroblast Growth Factor 21 (FGF21) is Required for the Full Anorectic Effect of the Glucagon-Like Peptide-1 Receptor Agonist Liraglutide in Male Mice fed High Carbohydrate Diets.肝脏成纤维细胞生长因子21(FGF21)是高碳水化合物饮食雄性小鼠中胰高血糖素样肽-1受体激动剂利拉鲁肽产生完全厌食作用所必需的。
bioRxiv. 2023 Jan 3:2023.01.03.522509. doi: 10.1101/2023.01.03.522509.
3
The quantity, quality and findings of network meta-analyses evaluating the effectiveness of GLP-1 RAs for weight loss: a scoping review.评估胰高血糖素样肽-1受体激动剂(GLP-1 RAs)减肥效果的网状Meta分析的数量、质量及结果:一项范围综述
Health Technol Assess. 2025 Jun 25:1-73. doi: 10.3310/SKHT8119.
4
GLP-1 receptor signaling increases PCSK1 and β cell features in human α cells.GLP-1 受体信号转导增加人α细胞中的 PCSK1 和β细胞特征。
JCI Insight. 2021 Feb 8;6(3):141851. doi: 10.1172/jci.insight.141851.
5
Hepatic Fibroblast Growth Factor 21 Is Involved in Mediating Functions of Liraglutide in Mice With Dietary Challenge.肝成纤维细胞生长因子 21 参与介导利拉鲁肽在饮食挑战小鼠中的作用。
Hepatology. 2021 Oct;74(4):2154-2169. doi: 10.1002/hep.31856. Epub 2021 Aug 30.
6
Leptin Reduction as a Required Component for Weight Loss.瘦素降低是减肥的必要组成部分。
Diabetes. 2024 Feb 1;73(2):197-210. doi: 10.2337/db23-0571.
7
Saponins from Enhance Lipolysis via Acting on FGF21-β-Klotho/FGFR1 in Obese Mice.来自[具体来源未给出]的皂苷通过作用于肥胖小鼠中的FGF21-β-klotho/FGFR1增强脂肪分解。
J Agric Food Chem. 2025 Jun 25;73(25):15624-15636. doi: 10.1021/acs.jafc.5c01012. Epub 2025 Jun 13.
8
Antibody blockade of activin type II receptors preserves skeletal muscle mass and enhances fat loss during GLP-1 receptor agonism.抗体阻断激活素 II 型受体可在 GLP-1 受体激动剂作用下保留骨骼肌质量并促进脂肪丢失。
Mol Metab. 2024 Feb;80:101880. doi: 10.1016/j.molmet.2024.101880. Epub 2024 Jan 11.
9
Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials.胰高血糖素样肽-1 受体激动剂对体重减轻的影响:随机对照试验的系统评价和荟萃分析。
BMJ. 2012 Jan 10;344:d7771. doi: 10.1136/bmj.d7771.
10
Prepregnancy GLP-1RA use improves maternal lipid metabolism via liver-secreted FGF21 during pregnancy in HFD-fed dams.在高脂饮食喂养的母鼠孕期,孕前使用胰高血糖素样肽-1受体激动剂(GLP-1RA)可通过肝脏分泌的成纤维细胞生长因子21(FGF21)改善母体脂质代谢。
Obesity (Silver Spring). 2025 Aug;33(8):1504-1517. doi: 10.1002/oby.24328. Epub 2025 Jul 9.

引用本文的文献

1
Adipose Tissue, at the Core of the Action of Incretin and Glucagon-Based Anti-Obesity Drugs.脂肪组织,肠促胰岛素和基于胰高血糖素的抗肥胖药物作用的核心。
Curr Obes Rep. 2025 Sep 2;14(1):67. doi: 10.1007/s13679-025-00660-w.
2
Exploring synergistic therapy for metabolic dysfunction-associated steatotic liver disease.探索代谢功能障碍相关脂肪性肝病的协同治疗方法。
Prz Gastroenterol. 2025;20(2):115-120. doi: 10.5114/pg.2025.151891. Epub 2025 Jun 6.
3
GLP-1/GLP-1R axis: from metabolism (obesity and T2DM) to immunity.胰高血糖素样肽-1/胰高血糖素样肽-1受体轴:从代谢(肥胖症和2型糖尿病)到免疫
Open Biol. 2025 Jan;15(7):240303. doi: 10.1098/rsob.240303. Epub 2025 Jul 2.
4
FGF21 analogue PF-05231023 on alcohol consumption and neuronal activity in the nucleus accumbens.成纤维细胞生长因子21类似物PF-05231023对酒精摄入及伏隔核神经元活动的影响
Neuropsychopharmacology. 2025 May 26. doi: 10.1038/s41386-025-02133-z.
5
FGF21 reverses MASH through coordinated actions on the CNS and liver.成纤维细胞生长因子21(FGF21)通过对中枢神经系统和肝脏的协同作用逆转代谢相关脂肪性肝病(MASH)。
Cell Metab. 2025 Jul 1;37(7):1515-1529.e6. doi: 10.1016/j.cmet.2025.04.014. Epub 2025 May 13.
6
The Chimeric Peptide (GEP44) Reduces Body Weight and Both Energy Intake and Energy Expenditure in Diet-Induced Obese Rats.嵌合肽(GEP44)可降低饮食诱导肥胖大鼠的体重、能量摄入和能量消耗。
Int J Mol Sci. 2025 Mar 26;26(7):3032. doi: 10.3390/ijms26073032.
7
Hepatic fibroblast growth factor 21 is required for curcumin or resveratrol in exerting their metabolic beneficial effect in male mice.姜黄素或白藜芦醇在雄性小鼠中发挥代谢有益作用需要肝脏成纤维细胞生长因子21。
Nutr Diabetes. 2025 Feb 10;15(1):4. doi: 10.1038/s41387-025-00363-0.
8
The Chimeric Peptide (GEP44) Reduces Body Weight and Both Energy Intake and Energy Expenditure in Diet-Induced Obese Rats.嵌合肽(GEP44)可降低饮食诱导肥胖大鼠的体重、能量摄入和能量消耗。
bioRxiv. 2025 Feb 22:2025.01.06.631534. doi: 10.1101/2025.01.06.631534.
9
Free fatty acid receptor 4 modulates dietary sugar preference via the gut microbiota.游离脂肪酸受体4通过肠道微生物群调节饮食中的糖偏好。
Nat Microbiol. 2025 Feb;10(2):348-361. doi: 10.1038/s41564-024-01902-8. Epub 2025 Jan 13.
10
Obesity, Osteoarthritis, and Myokines: Balancing Weight Management Strategies, Myokine Regulation, and Muscle Health.肥胖、骨关节炎与肌动蛋白:平衡体重管理策略、肌动蛋白调节与肌肉健康。
Nutrients. 2024 Dec 7;16(23):4231. doi: 10.3390/nu16234231.